stockrowImunon, Inc.
IMNN Healthcare Biotechnology
Imunon, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $500,000.00.
- EPS
- +74.9%
- Free cash flow
- −4.24%
Quarter to June 2026, against a year earlier
Follow IMNN
Alert me
Imunon, Inc. (IMNN) EV/Sales
As of 6 November 2026, Imunon, Inc. (IMNN) trades at a EV/Sales of 6.2×. Over the past ten years it has ranged from −55.0× (April 2021) to 220× (June 2020); the current reading is higher than 31% of that period. That is below the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2022 | −36.5× | — |
| FY2021 | 32.5× | 149.08% |
| FY2020 | 13.0× | (74.50%) |
| FY2019 | 51.2× | 656.27% |
| FY2018 | 6.8× | — |
| FY2017 | −8.3× | — |
| FY2016 | 8.3× | (78.05%) |
| FY2015 | 37.7× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Dec 2022 | −36.5× | — |
| Sep 2022 | −43.3× | — |
| Jun 2022 | −50.0× | — |
| Mar 2022 | −20.0× | — |
| 28 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CANF Can-Fite Biopharma Ltd compare | −8.7× |
| SNTI Senti Biosciences, Inc. compare | −1.1× |
| RVPH Reviva Pharmaceuticals Holdings, Inc. compare | n/m |
| ACXP Acurx Pharmaceuticals, Inc. compare | n/m |
| PULM Pulmatrix, Inc. compare | 0.8× |
| CNSY Cerenome, Inc. compare | 1.5× |
| IMNN Imunon, Inc. | 6.2× |
| PCSA Heatwurx Inc. compare | 49.5× |
| CDIO Cardio Diagnostics Holdings, Inc. compare | 61.5× |
| Biotechnology industry median | 9.0× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)